A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors
- Carolyn D. Britten
- , Elizabeth Garrett-Mayer
- , Steven H. Chin
- , Keisuke Shirai
- , Besim Ogretmen
- , Tricia A. Bentz
- , Alan Brisendine
- , Kate Anderton
- , Susan L. Cusack
- , Lynn W. Maines
- , Yan Zhuang
- , Charles D. Smith
- , Melanie B. Thomas
Research output: Contribution to journal › Article › peer-review
153
Link opens in a new tab
Scopus
citations